IMC Chicago’s GeneDx Holdings WGS Stock Holding History

IMC Chicago’s Portfolio WGS Stock Details WGS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$878K	Buy	12,794 +8,151	+176%	+$463K	﹤0.01%	4014
2026 Q1	$298K	Buy	+4,643	New	+$423K	﹤0.01%	4594

Other funds holding WGS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return

AAP

Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

IMC Chicago's WGS Position: Q2 2026 in Review

IMC Chicago increased its GeneDx Holdings (WGS) stake by 176% in Q2 2026, buying an estimated $463K and bringing the position to 12,794 shares worth $878K. The position accounts for ﹤0.01% of the portfolio, ranked #4014.

IMC Chicago first reported a position in WGS in Q1 2026 and has held it in 2 quarters since. 77 funds tracked by Wall St. Rank hold WGS as of Q2 2026.

IMC Chicago held 12,794 shares of GeneDx Holdings worth $878K as of Q2 2026.
IMC Chicago bought 8,151 GeneDx Holdings shares in Q2 2026, an estimated $463K.
GeneDx Holdings made up ﹤0.01% of IMC Chicago's portfolio in Q2 2026, its #4014 holding.
IMC Chicago first reported a position in GeneDx Holdings in Q1 2026 and has held it in 2 quarters since.
77 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2026.

Based on IMC Chicago's 13F filing for Q2 2026, filed 6 Aug 2026.